BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38222696)

  • 1. Mucopolysaccharidosis type I Hurler-Scheie syndrome: a case report.
    Lamichhane S; Sapkota A; Sapkota S; Adhikari N; Aryal S; Adhikari P
    Ann Med Surg (Lond); 2024 Jan; 86(1):588-593. PubMed ID: 38222696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orofacial features of Scheie (Hurler-Scheie) syndrome (alpha-L-iduronidase deficiency).
    Keith O; Scully C; Weidmann GM
    Oral Surg Oral Med Oral Pathol; 1990 Jul; 70(1):70-4. PubMed ID: 2115154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hurler-Scheie syndrome in Niger: a case series.
    Assadeck H; Toudou Daouda M; Bako H; Hassane Djibo F
    J Med Case Rep; 2019 Apr; 13(1):102. PubMed ID: 31018863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent allelism of the Hurler, Scheie, and Hurler/Scheie syndromes.
    Mueller OT; Shows TB; Opitz JM
    Am J Med Genet; 1984 Jul; 18(3):547-56. PubMed ID: 6433708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucopolysaccharidosis Type I.
    Kubaski F; de Oliveira Poswar F; Michelin-Tirelli K; Matte UDS; Horovitz DD; Barth AL; Baldo G; Vairo F; Giugliani R
    Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32188113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Remmington T
    Cochrane Database Syst Rev; 2016 Apr; 4():CD009354. PubMed ID: 27033167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009354. PubMed ID: 24257962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009354. PubMed ID: 24085657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucopolysaccharidosis type I Hurler-Scheie syndrome: A rare case report.
    Tatapudi R; Gunashekhar M; Raju PS
    Contemp Clin Dent; 2011 Jan; 2(1):66-8. PubMed ID: 22114460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme replacement therapy with laronidase (Aldurazyme
    Jameson E; Jones S; Remmington T
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD009354. PubMed ID: 31211405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.
    Stevenson RE; Howell RR; McKusick VA; Suskind R; Hanson JW; Elliott DE; Neufeld EF
    Pediatrics; 1976 Jan; 57(1):111-22. PubMed ID: 813180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybridization studies of fibroblasts from Hurler, Scheie, and Hurler/Scheie compound patients: support for the hypothesis of allelic mutants.
    Fortuin JJ; Kleijer WJ
    Hum Genet; 1980 Feb; 53(2):155-9. PubMed ID: 6766899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mucopolysaccharidosis I, Hurler syndrome: a case report].
    Amorín M; Carlin A; Prötzel A
    Arch Argent Pediatr; 2012 Oct; 110(5):e103-6. PubMed ID: 23070190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Craniofacial abnormalities in a murine knock-out model of mucopolysaccharidosis I H: a computed tomography and anatomic study.
    Graupman P; Pan D; Konair B; Hartung S; McIvor S; Whitley C; Low W; Lam CH
    J Craniofac Surg; 2004 May; 15(3):392-8. PubMed ID: 15111796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hurler Syndrome (Mucopolysaccharidosis Type 1): A Case Report.
    Khalid N; Abdullah M; Awais AB; Hassan M; Muhammad A
    Cureus; 2023 Apr; 15(4):e37785. PubMed ID: 37213966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early disease progression of Hurler syndrome.
    Kiely BT; Kohler JL; Coletti HY; Poe MD; Escolar ML
    Orphanet J Rare Dis; 2017 Feb; 12(1):32. PubMed ID: 28193245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndrome.
    Ahmed A; Whitley CB; Cooksley R; Rudser K; Cagle S; Ali N; Delaney K; Yund B; Shapiro E
    Mol Genet Metab; 2014 Feb; 111(2):123-7. PubMed ID: 24368159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of Mexican patients with Mucopolysaccharidosis type I.
    Alonzo-Rojo A; García-Ortiz JE; Ortiz-Aranda M; Gallegos-Arreola MP; Figuera-Villanueva LE
    Genet Mol Res; 2017 Sep; 16(3):. PubMed ID: 28973713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Manifestations of Hurler-Scheie Syndrome: Recurrence of Host Disease in the Corneal Transplant.
    Kölkedi Z; Csutak A; Szalai E
    Mol Syndromol; 2023 Feb; 14(1):44-50. PubMed ID: 36777710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.